Stock search

Ticker or company name

Dexcom

DXCM · NASDAQ · Health Care

$81,61Down −1,72 (−2,06%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$31,1 bn
Div. yield
—
Year to date
+25,6%
52 weeks: $56,72$92,59

Ratio score

89/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

8 ✓ · 0 — · 1 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM31,476,425,1
Forward P/E26,8—16,2
PEG1,4—2,2
P/S6,110,82,2
EV/EBITDA21,066,917,3
P/FCF28,3—19,5
P/B12,315,33,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 36 analysts

Buy
32
Hold
4
Sell
0

Beat the EPS forecast in 3 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20260,690,73Up +6,2%
Q2 20260,620,70Up +12,4%
Q1 20260,480,56Up +17,0%
Q4 20250,660,45Down −32,1%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue1,34 bn1,31 bn1,19 bn1,26 bn1,21 bn1,16 bn1,04 bn1,11 bn994 m1,00 bn921 m1,03 bn
EPS0,720,640,510,670,700,450,270,380,340,350,360,61
Margin20,5%19,0%16,7%21,2%23,5%15,5%10,2%13,6%13,5%14,3%15,9%24,8%
FCF273 m185 m449 m192 m579 m209 m96,8 m177 m88,3 m213 m152 m81,1 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $12,2 m.

NameAmountSharesPrice
stern sadie27 Oct 2026 · sale$201 6602 565$78,62
augustinos nicholas15 Sep 2026 · sale$549 5386 539$84,04
brown michael jon15 Sep 2026 · sale$142 8681 700$84,04
augustinos nicholas14 Sep 2026 · sale$130 2311 550$84,02
sylvain jereme m10 Sep 2026 · sale$302 9363 638$83,27
stern sadie27 Aug 2026 · sale$226 6692 565$88,37
sayer kevin r20 Aug 2026 · sale$8 86797$91,41
sayer kevin r20 Aug 2026 · sale$667 3327 351$90,78
sayer kevin r20 Aug 2026 · sale$1,73 m19 308$89,71
brown michael jon14 Aug 2026 · sale$156 2811 700$91,93
heller bridgette p12 Aug 2026 · sale$89 3491 012$88,29
foletta mark g3 Aug 2026 · sale$170 6402 000$85,32
foletta mark g31 Jul 2026 · sale$160 0002 000$80,00
sayer kevin r20 Jul 2026 · sale$2,04 m26 756$76,32
brown michael jon15 Jul 2026 · sale$126 5141 700$74,42

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NASDAQ
Country
US
IPO date
14 Apr 2005

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
LHLabcorp$372,4656would watch30,0+6,0%6,9%
DGXQuest Diagnostics$262,2161would watch25,5+9,1%9,5%
RMDResMed$238,1983would consider21,3+9,0%27,8%
CNCCentene Corporation$74,7772would consider24,2+9,7%0,7%
GEHCGE HealthCare$82,96no score17,4——
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.